Large-scale, spatially resolved panoramic CRISPR screening in native tissue environments using Perturb-DBiT

Read full text
Authors: Alev Baysoy, Xiaolong Tian, Paul Renauer, Feifei Zhang, Zhiliang Bai, Hao Shi, Mingyu Yang, Dingyao Zhang, Miao Liu, Haikuo Li, Bo Tao, Archibald Enninful
+23 more L. Yao, Fu Gao, Guangchuan Wang, Wanqiu Zhang, Thao Tran, Nathan Heath Patterson, Jie Sheng, Shuozhen Bao, Chuanpeng Dong, Xin Shan, B Chen, Mei Zhong, Sherri Rankin, Cliff Guy, Yan Wang, Jon P. Connelly, Shondra M. Pruett‐Miller, Daifeng Wang, Mina L. Xu, M. Gerstein, Hongbo Chi, Sidi Chen, Rong Fan
Cited by: 10
References: 109

Abstract

Spatially resolved CRISPR screening in vivo has been limited to small perturbation panels and subsets of protein-coding RNAs. We present Perturb-DBiT, a method for co-sequencing of spatial total RNA whole transcriptomes and single guide RNAs (sgRNAs) on the same tissue section in situ. In a human cancer metastatic colonization model, we applied large (80,000+) sgRNA panels across tumor colonies in multiple consecutive tissue sections alongside their corresponding total RNA transcriptomes. We linked perturbations affecting long noncoding RNA covariation, microRNA-mRNA interactions and distinct amino acid-specific tRNA alterations to tumor migration and growth. By integrating transcriptional pseudotime trajectories, we further observed the impact of perturbations on clonal dynamics and cooperation. In an immune-competent syngeneic mouse model, investigation of the tumor immune microenvironment indicated distinct, synergistic effects on immune infiltration and suppression. Perturb-DBiT provides a spatially resolved comprehensive view of perturbation responses in complex tissues, including small and large RNA regulation, tumor proliferation, migration, metastasis and immune interactions.

Fields of Study & Subjects

Single-cell and spatial transcriptomics CRISPR and Genetic Engineering Cancer Genomics and Diagnostics

Publication details

Journal / source
Nature Biotechnology
Publisher
Springer Science and Business Media LLC
Publication date
11 June 2026
Language
EN